MIRXES-B(02629),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02629 MIRXES-B

Not Yet Opened 02-10 16:09:14

23.720

-0.400

-1.66%

High24.640	Low23.560	Vol4.34M
Open24.600	D1 Closing24.120	Amplitude4.48%
Mkt Cap7.07B	Tradable Cap7.07B	Total Shares298.00M
T/O104.11M	T/O Rate1.46%	Tradable Shares298.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":23.72,"timestamp":1770710954009,"preClose":24.12,"halted":0,"volume":4341200,"delay":0,"changeRate":-0.016583747927031597,"floatShares":298000000,"shares":298000000,"eps":-0.76899,"marketStatus":"Not Yet Opened","change":-0.4,"latestTime":"02-10 16:09:14","open":24.6,"high":24.64,"low":23.56,"amount":104111052,"amplitude":0.044776,"askPrice":23.76,"askSize":3500,"bidPrice":23.72,"bidSize":3700,"shortable":3,"etf":0,"ttmEps":-2.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":24.12,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":1.3625606548142124,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02629","defaultTab":"news","newsList":[{"id":"2609804532","title":"Mirxes Nets HK$673 Million via Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2609804532","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609804532?lang=en_us&edition=fundamental","pubTime":"2026-02-06 10:27","pubTimestamp":1770344861,"startTime":"0","endTime":"0","summary":"Mirxes  completed a placing of 21.9 million new shares at HK$32.50 each, generating net proceeds of about HK$673.4 million, according to a Thursday Hong Kong bourse filing.Shares of the micro ribonucleic acid technology firm were down more than 4% in Friday morning trade.The shares were placed to no fewer than six independent investors under a general mandate, the company said.Mirxes said it plans to deploy the net proceeds toward investments and mergers and acquisitions, research and development, including clinical programs, expansion into emerging markets, and general working capital.Following the placing, the issued share capital increased to 298.2 million shares, with the placees holding about 7.3% of the enlarged share base.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1112952136","title":"MIRXES-B Completes Placement of 21.888 Million Shares, Raising Approximately HK$673 Million Net Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=1112952136","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112952136?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:42","pubTimestamp":1770284536,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) has announced that all conditions have been fulfilled, and the settlement was completed on February 5, 2026. A total of 21.888 million placement shares were successfully allocated by...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2609201713","title":"Mirxes Forms Joint Venture With Xeraya to Develop Cancer Diagnostics in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2609201713","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609201713?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:31","pubTimestamp":1770283875,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd., through its wholly-owned subsidiary Mirxes International Holding Limited, has entered into a joint venture agreement with Xeraya Opportunities Fund PCC Limited to establish MYRNA DIAGNOSTICS SDN. BHD. The joint venture will focus on the research, development, commercialization, and regulatory approval of cancer early detection and other nucleic acid-based tests in Malaysia. Mirxes International Holding Limited will hold a 40% stake in the new company, while Xeraya will hold 60%. Both parties have agreed to contribute a total of approximately US$5 million in proportion to their respective equity interests. Additionally, on December 15, 2025, Mirxes Holding Co. Ltd. entered into a strategic partnership with N Health, a member of the Bangkok Dusit Medical Services  Group, aiming to introduce advanced microRNA  cancer screening solutions to Thailand. This collaboration is expected to enhance early cancer detection and improve patient outcomes across Thailand and th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7dR0fR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1109400351","title":"Guosen Securities: Cancer Genetic Testing Industry in Fast Lane with Multi-fold Market Expansion Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1109400351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109400351?lang=en_us&edition=fundamental","pubTime":"2026-02-03 14:47","pubTimestamp":1770101228,"startTime":"0","endTime":"0","summary":"Guosen Securities released a research report stating that since Q4 2025, the cancer genetic testing sector has witnessed continuous hotspots, frequent major international transactions, and domestic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","002736","BK0183","BK0276","BK0028","BK1161","BK0188"],"gpt_icon":0},{"id":"2607209427","title":"BRIEF-MiRXES Holding Announces Placing 21.9 Million Shares At HK$32.50/ Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2607209427","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607209427?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:28","pubTimestamp":1769650135,"startTime":"0","endTime":"0","summary":"BRIEF-MiRXES Holding Announces Placing 21.9 Million Shares At HK$32.50/ ShareJan 29 (Reuters) - MiRXES Holding Co Ltd 2629.HK:PLACING 21.9 MILLION SHARES AT HK$32.50 PER PLACING SHAREFurther company coverage: 2629.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1188076240","title":"MIRXES-B (02629) Plans Placement of 21.888 Million Shares at 11.88% Discount, Targeting Net Proceeds of ~HK$673 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1188076240","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188076240?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:16","pubTimestamp":1769645783,"startTime":"0","endTime":"0","summary":"On January 29, 2026 (before the trading session), the company entered into a placement agreement with a placing agent, whereby the company agreed to appoint the agent, who, in turn, agreed to act...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2607724611","title":"Mirxes Holding - Placing 21.9 Mln Shares at HK$32.50 per Placing Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2607724611","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607724611?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:08","pubTimestamp":1769645285,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2607724613","title":"Mirxes Holding Announces HK$711 Million Private Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2607724613","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607724613?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:07","pubTimestamp":1769645269,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. announced that it has entered into a Placing Agreement with placing agents to issue 21,888,000 new shares at a placing price of HK$32.50 per share. The shares will be placed with at least six independent professional, institutional, and other investors, all of whom are independent third parties. The placement will be conducted under the company’s general mandate, which allows the directors to allot, issue, or deal with additional shares not exceeding 20% of the issued share capital as of the date of the last annual general meeting. The shares will not be offered to the public in the United States or any other jurisdiction where such an offering would be unlawful. The placement is subject to certain conditions and may or may not proceed. Investors are advised to exercise caution when dealing in the company’s securities.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL7STrCs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1190989426","title":"Zhitoong Hong Kong Stock Short Selling Statistics | January 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1190989426","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190989426?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:27","pubTimestamp":1768436879,"startTime":"0","endTime":"0","summary":"AIA-R (81299), ANTA Sports-R (82020), and Great Wall Motor-R (82333) recorded the highest short selling ratios in the previous trading session, each reaching 100.00%. Alibaba-W (09988), Tencent...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1439103000.SGD","LU0477156797.USD","LU0348814723.USD","LU0417516902.SGD","LU0865486749.SGD","SG9999014906.USD","LU1224709979.USD","SG9999014898.SGD","BYDDF","LU0348783662.USD","IE00BVYPNQ40.USD","LU0106959298.USD","LU0289960550.SGD","SUHJY","BK4587","LU0359202008.SGD","600377","LU0650527681.SGD","BK1539","LU0264606111.USD","LU0545039389.USD","SG9999001051.SGD","LU0594300419.USD","00016","LU0414403682.SGD","LU0675040207.SGD","LU0633140727.USD","BK1608","IE00B29SXG58.USD","LU0047713382.USD","LU2257852520.SGD","LU1868838027.USD","LU1629966141.USD","LU0348827113.USD","IE00BZ18W456.USD","LU0231483743.USD","LU0531971595.HKD","LU0823039010.USD","LU0862451837.USD","LU1720051017.SGD","LU0608807946.USD","LU0821914370.USD","BK1193","LU0588545490.SGD","LU1880383366.USD","LU1688375341.USD","SG9999013353.USD","BK1526","LU1201861165.SGD","LU0762542818.HKD","LU1813983027.USD","SG9999001226.SGD","SGXZ31699556.SGD","SG9999004220.SGD","LU0593848301.USD","LU0096374516.USD","BK1559","LU0873338254.USD","LU0048597586.USD","01024","BK1515","LU0061477393.USD","LU2097828631.EUR","IE0003795394.USD","IE0008369823.USD","LU0181495838.USD","LU0737861772.HKD","LU1102505929.USD","SG9999014914.USD","BK4575","LU2097828714.EUR","LU0541501648.USD","LU0080751232.USD","LU2293587155.HKD","SJMHY","LU1718418525.SGD","03145","BK1567","BK1142","HK0000306685.HKD","LU0594300179.USD","LU1880398471.USD","09992","LU0348735423.USD","LU1794554557.SGD","LU1568876335.HKD","IE0001KFT4U8.USD","LU0577902371.SGD","LU1152091168.USD","GWLLY","LU0163747925.USD","LU2237443978.SGD","LU2088748020.USD","LU2449936058.SGD","BK4535","LU1993786604.SGD","HK0000352382.USD","LU1481107354.HKD","LU1642822792.SGD","LU0455707207.USD","LU1831875114.USD","LU1720051108.HKD","80700","00241","LU1224444064.USD","LU1196710351.USD","LU0499858602.USD","BK1607","BK4579","LU1226288253.USD","SG9999001903.USD","82318","LU1960683339.HKD","SG9999000327.SGD","BK4588","00700","LU0254981946.USD","LU1044874839.SGD","LU0488056044.USD","LU1675838814.USD","HK0000320264.USD","LU0831093199.SGD","LU0235996351.USD","LU2088747998.USD","LU0117844026.USD","LU0502904849.HKD","LU2265009873.SGD","BK4526","LU0043850808.USD","LU0972618739.USD","BK4565","XIACY","LU0640798160.USD","LU0501845795.SGD","SG9999006597.SGD","LU2125910849.SGD","LU0320764599.SGD","LU0786609619.USD","LU2357305700.SGD","LU1951186391.HKD","BK1521","LU0577902454.USD","LU0648000940.SGD","LU0345769631.USD","BK1604","LU0067412154.USD","SG9999002463.SGD","LU0797268264.HKD","BK4538","LU1226287792.SGD","IE00B1G9TL16.USD","00880","BK4505","LU2237443382.USD","LU0708995153.HKD","LU0211331839.USD","LU0229945570.USD","BK1227","LU1917777945.USD","LU1316542783.SGD","LU0261950983.USD","BK1523","LU2399975544.HKD","LU0072462343.USD","ANPDY","LU2247934214.USD","83690","LU0577902298.EUR","LU0169518387.USD","IE0032431581.USD","LU0605514214.HKD","LU2543165471.USD","IE00B8HQ1Z84.USD","LU2348774022.SGD","HK0000320223.HKD","LU0541502299.USD","LU0823038988.USD","LU2317271919.USD","IE00BPRC5H50.USD","BK1185","LU0762541174.USD","LU0214875030.USD","SG9999015986.USD","BK4558","BK1517","LU1303224171.USD","BK1240","SGXZ90724238.SGD","LU2226123227.USD","BK1506","LU0348767384.USD","LU0251143458.SGD","BYDDY","LU0348825331.USD","LU0359201612.USD","89988","LU0348784397.USD","601628","BK1095","HBBD.SI","LU1242518857.USD","IE00BVYPNP33.GBP","LU0509642566.USD","LU1719994722.HKD","IE00B97KM107.HKD","LU0051755006.USD","IE0008368304.USD","IE00BMQBXF63.USD","LU1282648689.USD","601318","LU0149534421.HKD","LU1770036033.HKD","BABA","LU0149721374.USD","LU2097828474.EUR","LU0784639295.USD","LU0456846285.SGD","LU2362540622.SGD","LU0348816934.USD","LU0608807433.USD","LU0516422952.EUR","BK4548","LU2148611432.USD","BK1617","LU0329678337.USD","LU0918141887.USD","LU0320764243.SGD","LU0326948709.USD","BK4531","LU0543330566.HKD","82333","80992","LU0345775950.USD","IE00BF5LJ272.USD","HPAD.SI","LU0143863198.USD","LU1226288097.SGD","PNGAY","LU0370786039.SGD","02318","03690","BK4122","LU2051468812.USD","LU0878005551.USD","IE0031814852.USD","LU0210533765.USD","LU1323998911.USD","LU2237443465.HKD","LU0651946864.USD","LU2039709279.SGD","LU1316543674.SGD","LU1733274473.HKD","LU0642271901.SGD","BK4585","LU0228659784.USD","KSTmain","GB00BDT5M118.USD","03121","IE00BMCWC346.EUR","LU0630378429.USD","LU2778985437.USD","LU0345776255.USD","LU0106252389.USD","LU0128522744.USD","LU1152091754.HKD","LU2362541513.USD","LU0898667661.SGD","BK1571","LU0348788117.USD","LU1883866441.USD","BK1172","IE00B0169L03.USD","SG9999012744.USD","LU1328615791.USD","BK1531","LU0192582467.USD","LU0164872284.USD","LU1282649810.SGD","MPNGY","LU1048484197.HKD","BK4543","PAImain","BK4503","HK0000914660.USD","LU1048596156.SGD","LU1439102457.SGD","IE0008368742.USD","LU0251144936.SGD","LU2251237306.USD","LU0449509016.USD","BK1189","LU0314109678.HKD","IE0003851619.USD","LU1003077747.HKD","LU1725190679.HKD","HK0000165453.HKD","LU0188438112.USD","SG9999010052.SGD","SG9999003461.SGD","BK1534","LU0359201885.HKD","LU0048388663.USD","LU0197773673.USD","TCEHY","002594","IE00BQXX3C00.GBP","LU0348766576.USD","81024","LU0648948544.HKD","SG9999015978.USD","IE00B031HW06.USD","ALBmain","LU0326950275.SGD","BK4614","LU1655091459.SGD","LU2045819591.USD","IE0009570106.USD","IE00BFMHRM44.USD","SG9999015945.SGD","LU0127658192.USD","LU2133065610.SGD","SGXZ86797644.SGD","LU0543330483.HKD","LU1196710864.SGD","LU0197773160.USD","SG9999002828.SGD","HK0000352291.HKD","HK0000306701.USD","BK1216","LU0823426480.USD","SG9999014880.SGD","MIUmain","BK1184","LU0862451753.SGD","LU1064131003.USD","LU1868837722.USD","SG9999017495.SGD","LU0348783233.USD","LU0886674414.USD","LU1814569148.SGD","LU0456842615.SGD","LU1880398554.USD","HTCD.SI","BK4502","TCOM","LU0856984785.SGD","LU0039217434.USD","IE00B031J352.USD","LU0165289439.USD","LU1807302812.USD","SG9999006514.SGD","LU1064130708.USD","SG9999010078.USD","IE00BGHQDM52.EUR","LU0828237940.HKD","IE00B1G9TM23.USD","LU0890818403.SGD","SG9999018857.SGD","LU0516422366.SGD","LU2152927971.USD","BK1501","LU0469268626.HKD","LU1769817096.USD","LU1956131251.USD","LU1046422090.SGD","LU0052750758.USD","LU0588545730.USD","LU0348723411.USD","BK4524","LU0672654166.SGD","LU0315178854.USD","BK4533","SGXZ99366536.SGD","LU2153592121.USD","LU0918141705.HKD","BK1247","LU0054450605.USD","LU0949170772.SGD","LU1974910355.USD","LU3063872942.SGD","LU0261947096.USD","LU0441854154.USD","LU1366334651.USD","LU0762540952.USD","LU0561508036.HKD","LU0327786744.USD","SG9999012728.SGD","LU0572944931.SGD","LU0384037296.USD","BK1249","LU0700851271.USD","LU0054237671.USD","LU0196878994.USD","LU0577902611.USD","LU1046421795.USD","SG9999012736.USD","LU0029874905.USD","82020","81211","LU2279701549.SGD","LU1770034418.SGD","BK1591","LU0210527791.USD","LU0084288322.USD","LU0607220059.USD","LU2106854487.HKD","LU0823413660.USD","LU2097829019.USD","LU0431992006.USD","IE0008368411.USD","WARFY","LU0315179316.USD","LU0633140560.USD","80291","BK1601","LU0417516571.SGD","LU0553294199.USD","LU0868486357.SGD","LU0572940350.SGD","LU2023250504.SGD","LU0048580855.USD","LU0819123356.HKD","LU2008162690.USD","BK4504","BK1575","BK1584","BK1588","LU0823040885.USD","BK4534","LU2251237488.HKD","LU1051768304.USD","BK1502","LU0011963245.USD","LU0878004406.USD","LU0540923850.HKD","LU2148510915.USD","LU0072913022.USD","BK1507","SG9999002950.SGD","LU2237443549.SGD","IE00BMPRXR70.SGD","BK1516","LU0823426308.USD","BK4554","00177","LU0287142896.SGD","LU0985320562.USD","LU1282651048.USD","LU1880383440.USD","LU1226288170.HKD","BK1618","LU0456827905.SGD","09961","LU0348805143.USD","LU0589944569.HKD","LU0070217475.USD","IE00BZ08YR35.GBP","BK4607","BK4581","00004","LU1242518931.SGD","LU2226246903.HKD","LU1568876251.USD","SG9999001069.SGD","IE00B067MR52.USD","LU0499858438.USD","LU1226287529.USD","LU0052756011.USD","BK1615","BK1119","LU1146622755.USD","LU1188198961.HKD","LU0106259558.USD","LU0175139822.USD","LU1235294995.USD","LU0345769128.USD","LU0417516738.SGD","LU0029875118.USD","LU0819121731.USD","LU0516422440.USD","LU2177674079.SGD","LU0738911758.USD","SG9999007991.SGD","IE00B5MMRT66.SGD","LU0630378692.HKD","LU0329678170.USD","LU0396098781.USD","LU1008478684.HKD","LU0107464264.USD","LU2476274720.SGD","IE0032834883.USD","LU0128522157.USD","LU0572939691.SGD","BK1589","LU2226123490.SGD","BK1555","HXXD.SI","LU0259732245.USD","LU0871576103.HKD","LU1048588211.SGD","SG9999015952.SGD","LU0211977185.USD","LU1548497426.USD","LU1023057109.AUD","LU2237443895.HKD","LU0210526637.USD","AAGIY","SG9999002562.SGD","BK1609","LU0449515922.USD","LU0531970944.HKD","LU0128525689.USD","IE00BZ08YT58.USD","LU0117841782.USD","LU0979878070.USD","LU0738912210.USD","LU1251922891.USD","LU1961090484.USD","LU2488822045.USD","HMTD.SI","LU0588546209.SGD","LU0791591158.USD","LU1868837565.USD","LU0516423091.SGD","MIUmain","SG9999018865.SGD","LU1282649067.USD","LU0791590937.USD","LU1226287875.USD","BK1233","LU0130103400.USD","LU0320764755.SGD","LU1051769294.HKD","LU0269904917.USD","IE00BQXX3F31.USD","SGXZ62798434.SGD","LU1115378108.SGD","LU1820825898.SGD","LU1235295612.USD","LU2462611646.USD","LU0737861699.HKD","LU2097828557.USD","LU0823041008.USD","LU0516423174.USD","LU0831103253.SGD","LU1504937902.USD","09988","LU1733274390.USD","LU2498475776.HKD","LU0661504455.SGD","LU1366334578.USD","LU0132412106.USD","LU0307460666.USD","LU1044875133.USD","LU0143863784.USD","81299","LU2097828805.USD","LU2237443622.USD","LU2362541273.HKD","BK1586","BK1180","LU2125910500.SGD","IE00B543WZ88.USD","SG9999001689.USD","BK1583","HK0000914686.HKD","IE00B0169N27.USD","LU0708995583.HKD","IE00B3M56506.USD","METmain","LU0588545904.SGD","LU1785774172.SGD","LU0828238088.HKD","IE00BGV7N243.SGD","LU0228367735.SGD","LU0310800965.SGD","LU0828237510.HKD","LU1102505762.USD","01810","LU0823397285.USD","IE00B8L5B284.USD","LU1282649141.HKD","LU2088748293.HKD","LU1769817179.HKD","89618","LU0634319403.HKD","LU0173614495.USD","SG9999009997.SGD","LU0823397103.USD","LU0823413587.USD","LU0611395673.USD","LU0164865239.USD","LU0049112450.USD","IE00BQXX3D17.EUR","LU1282651121.HKD","LU1720050803.USD","LU2088748376.SGD","BK4220","LU1823568750.SGD","00884","LU0463099449.HKD","LU0203347892.USD","LU0577902538.SGD","LU0140636845.USD","LU1328277881.USD","LU0229494975.USD","IE00BMPRXN33.USD","SG9999000418.SGD","SG9999012710.SGD","IE0003895053.USD","SG9999001846.SGD","601633","LU0328353924.USD","LU0651947912.USD","JEXYY","LU0293314216.USD","LU2087589342.USD","IE00BZ18W340.USD","LU0203345920.USD","IE00BYV24P56.USD","LU1044876610.USD","LU0244354667.USD","02628","81810","IE00BZ08YS42.EUR","02629","PMRTY","BK1224","LU0130518102.USD","SG9999000459.SGD","LU1981816686.USD","LU1804176565.USD","SG9999014674.SGD","LU0164880469.USD","IE0034224299.USD","80016","SGXZ81514606.USD","BK4527","LU0683595622.HKD","SGXZ51526630.SGD","LU1211504680.USD","LU1734074674.USD","LU1810669033.SGD","IE00B0JY6N72.USD","LU2088747725.USD","BK1550","LU0880133367.SGD","BK1590","LU1515016050.SGD","SG9999001093.SGD","LU1267930227.SGD","LU0049853897.USD","LU0882747503.HKD","LU1196710195.USD","LU2242644610.SGD","LU1105468828.SGD","IE00B031HY20.USD","IE00BSPPW651.USD","LU1808992512.USD","BK1610","LU2476274308.USD"],"gpt_icon":1},{"id":"2602562569","title":"Mirxes Expands Thailand Business With Hospital Partnership, Home Test Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2602562569","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602562569?lang=en_us&edition=fundamental","pubTime":"2026-01-12 10:45","pubTimestamp":1768185929,"startTime":"0","endTime":"0","summary":"Mirxes  has formed a partnership in Thailand with N Health, a unit of Bangkok Dusit Medical Services , to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4195","02629","BK4211","HBCP","BK1161"],"gpt_icon":0},{"id":"1192699964","title":"MIRXES-B (02629) Establishes Strategic Partnership with N Health and Gains Regulatory Approval for HELICORapid and FITRapid At-Home Test Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=1192699964","media":"Stock News","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192699964?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:48","pubTimestamp":1767952136,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that the company has entered into a strategic partnership with N Health (a healthcare solutions provider and a member of Bangkok Dusit Medical Services (BDMS) Group,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2602432183","title":"Mirxes Holding Forms Strategic Partnership with N Health to Launch Cancer Screening in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2602432183","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602432183?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:39","pubTimestamp":1767951546,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited has announced the signing of a strategic partnership with N Health, a healthcare solutions provider and member of the Bangkok Dusit Medical Services  Group, Thailand's largest healthcare provider. The collaboration aims to introduce Mirxes' advanced microRNA  cancer screening solutions, including GASTROClear for gastric cancer and LUNGClear for lung cancer, across nearly 60 hospitals within N Health's network. This partnership is expected to enhance early cancer detection and improve patient outcomes in Thailand and the wider Southeast Asian region, supporting broader access to early disease detection and contributing to improved standards of cancer care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL2CjXyf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2602532921","title":"Mirxes - Partnership to Introduce Advanced Mirna Cancer Screening in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2602532921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602532921?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:38","pubTimestamp":1767951489,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA03Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2602032929","title":"Mirxes Holding Co Ltd - on Dec 15, Entered Strategic Partnership With N Health in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2602032929","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602032929?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:38","pubTimestamp":1767951489,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA03Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2595750874","title":"The recent pullback must have dismayed Mirxes Holding Company Limited (HKG:2629) insiders who own 44% of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=2595750874","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595750874?lang=en_us&edition=fundamental","pubTime":"2025-12-30 07:44","pubTimestamp":1767051850,"startTime":"0","endTime":"0","summary":"Key Insights Mirxes Holding's significant insider ownership suggests inherent interests in company's expansion A total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2629/mirxes-holding-shares/news/the-recent-pullback-must-have-dismayed-mirxes-holding-compan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2629/mirxes-holding-shares/news/the-recent-pullback-must-have-dismayed-mirxes-holding-compan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2589181308","title":"BRIEF-Mirxes Holding Enters MoU With Xtalpi Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2589181308","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589181308?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:54","pubTimestamp":1764946450,"startTime":"0","endTime":"0","summary":"BRIEF-Mirxes Holding Enters MoU With Xtalpi HoldingsDec 5 (Reuters) - MiRXES Holding Co Ltd 2629.HK:ENTERS MOU WITH XTALPI HOLDINGSCO AND XTALPI TO BUILD AI PLATFORM FOR ASIAN HIGH-INCIDENCE CANCERS, OTHERSFurther company coverage: 2629.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XA184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629","02228","BK1617","BK1141"],"gpt_icon":0},{"id":"1135315158","title":"MIRXES-B (02629) to Collaborate with XTALPI on AI-Powered Innovative \"Diagnosis-Treatment Integration\" Research and Industrialization Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1135315158","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135315158?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:12","pubTimestamp":1764933148,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that it has recently entered into a memorandum of understanding (MOU) with XTALPI Holdings Limited (XTALPI). Under the agreement, the two parties will combine MIRXES-B's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02228","02629","BK1617","BK1141"],"gpt_icon":0},{"id":"2589553899","title":"Mirxes Holding - Co and Xtalpi to Build AI Platform for Asian High-Incidence Cancers, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2589553899","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589553899?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:03","pubTimestamp":1764932596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XA184:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02629","BK1617","02228","BK1161","BK1141"],"gpt_icon":0},{"id":"2589537899","title":"Mirxes Holding Co Ltd - Enters Mou With Xtalpi Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2589537899","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589537899?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:03","pubTimestamp":1764932596,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XA184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2589899581","title":"Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2589899581","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589899581?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:03","pubTimestamp":1764932585,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding  with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled \"integrated diagnosis and intervention\" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL62B2Jb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0}],"profile":{"websiteUrl":"http://mirxes.com","stockEarnings":[{"period":"1week","weight":-0.2715},{"period":"1month","weight":-0.4775},{"period":"3month","weight":-0.6183},{"period":"6month","weight":-0.3637},{"period":"1year","weight":0.018},{"period":"ytd","weight":-0.4614}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0097},{"period":"6month","weight":0.0652},{"period":"1year","weight":0.263},{"period":"ytd","weight":0.0606}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"MiRXES Holding Company Limited is a micro ribonucleic acid (miRNA) technology company specializing in early cancer detection and precision medicine. It develops and commercializes accurate, non-invasive, and affordable blood-based miRNA test kit products for the early detection of cancer and other diseases. Its segments include Infectious diseases and Early detection and precision multi-omics. Its solutions include cancer screening; clinical sequencing; cancer treatment selection, and infectious diseases. Its core product (namely, GASTROClear), two other commercialized products (namely, LUNGClear and Fortitude), and six product candidates at pre-clinical stage. GASTROClear is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. LUNGClear, its lung cancer screening product candidate, is a detection panel consisting of miRNA biomarkers discovered and verified in multi-center studies. It offers complete COVID-19 testing solutions.","exchange":"SEHK","name":"MIRXES-B","nameEN":"MIRXES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MIRXES-B(02629),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MIRXES-B(02629) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MIRXES-B,02629,MIRXES-B股票,MIRXES-B股票老虎,MIRXES-B股票老虎国际,MIRXES-B行情,MIRXES-B股票行情,MIRXES-B股价,MIRXES-B股市,MIRXES-B股票价格,MIRXES-B股票交易,MIRXES-B股票购买,MIRXES-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MIRXES-B(02629),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MIRXES-B(02629) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}